129 related articles for article (PubMed ID: 6707188)
1. Demonstration of biological activity of prolactin molecular weight variants in human sera.
Whitaker MD; Klee GG; Kao PC; Randall RV; Heser DW
J Clin Endocrinol Metab; 1984 May; 58(5):826-30. PubMed ID: 6707188
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Nb2 bioassay and radioimmunoassay values for human serum prolactin.
Rowe RC; Cowden EA; Faiman C; Friesen HG
J Clin Endocrinol Metab; 1983 Nov; 57(5):942-6. PubMed ID: 6413527
[TBL] [Abstract][Full Text] [Related]
3. Molecular heterogeneity of prolactin in lactating rats and their pups: biological and immunological activities in pituitary gland, serum and milk.
Kacsóh B; Tóth BE; Avery LM; Yamamuro Y; Grosvenor CE
Endocr Regul; 1991 Jun; 25(1-2):98-110. PubMed ID: 1958841
[TBL] [Abstract][Full Text] [Related]
4. Characterization of big, big prolactin in patients with hyperprolactinaemia.
Leite V; Cosby H; Sobrinho LG; Fresnoza MA; Santos MA; Friesen HG
Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
[TBL] [Abstract][Full Text] [Related]
5. Bioactive and immunoreactive variants of prolactin in milk and serum of lactating rats and their pups.
Kacsóh B; Veress Z; Tóth BE; Avery LM; Grosvenor CE
J Endocrinol; 1993 Aug; 138(2):243-57. PubMed ID: 8228733
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses.
Jackson RD; Wortsman J; Malarkey WB
J Clin Endocrinol Metab; 1985 Aug; 61(2):258-64. PubMed ID: 4008606
[TBL] [Abstract][Full Text] [Related]
7. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients.
Leaños-Miranda A; Cárdenas-Mondragón G; Rivera-Leaños R; Ulloa-Aguirre A; Goffin V
Clin Endocrinol (Oxf); 2006 Aug; 65(2):146-53. PubMed ID: 16886952
[TBL] [Abstract][Full Text] [Related]
8. Prolactin size heterogeneity in human follicular fluid: a preliminary study.
Subramanian MG; Sacco AG; Moghissi KS; Lawson DM; Gala RR
Int J Fertil; 1991; 36(6):367-71. PubMed ID: 1684962
[TBL] [Abstract][Full Text] [Related]
9. The presence of macromolecular prolactin in serum of pregnant women and patients with pituitary adenoma.
Ohnami S; Eto S
J UOEH; 1985 Jun; 7(2):185-92. PubMed ID: 4023466
[TBL] [Abstract][Full Text] [Related]
10. Bioactive forms of serum lactogens: effects of treatment of prolactinoma patients with bromocriptine.
Rennie PS; Prior JC; Bruchovsky N; Gout PW
Clin Endocrinol (Oxf); 1985 Jan; 22(1):65-73. PubMed ID: 3978829
[TBL] [Abstract][Full Text] [Related]
11. Effects of cysteamine on pituitary, MTTW15 tumor, and serum prolactin levels measured by rat lymphoma cell bioassay and radioimmunoassay.
Parsons JA; Peterson EK; Hartfel MA
Endocrinology; 1984 May; 114(5):1812-7. PubMed ID: 6714167
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of prolactin secreted by human prolactinoma cells: immunological, receptor binding, and biological properties of the glycosylated and nonglycosylated forms.
Pellegrini I; Gunz G; Ronin C; Fenouillet E; Peyrat JP; Delori P; Jaquet P
Endocrinology; 1988 Jun; 122(6):2667-74. PubMed ID: 3131120
[TBL] [Abstract][Full Text] [Related]
13. Anti-prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia.
Hattori N; Nakayama Y; Kitagawa K; Ishihara T; Saiki Y; Inagaki C
Clin Endocrinol (Oxf); 2008 Jan; 68(1):72-6. PubMed ID: 17681026
[TBL] [Abstract][Full Text] [Related]
14. Bioactivity and glycosylation of circulating prolactin in various physiological and pathological conditions.
Gambino GM; Beck-Peccoz P; Borgato S; Faglia G; Spada A; Persani L
Pituitary; 1999 Nov; 2(3):225-31. PubMed ID: 11081158
[TBL] [Abstract][Full Text] [Related]
15. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay.
Rose DP; Berke B; Cohen LA
Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857
[TBL] [Abstract][Full Text] [Related]
16. Serum specifically potentiates the mitogenic response of Nb2 lymphoma cells to rat prolactin.
Moy JA; Lawson DM
Endocrinology; 1988 Sep; 123(3):1314-9. PubMed ID: 3402387
[TBL] [Abstract][Full Text] [Related]
17. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.
Jaquet P; Hassoun J; Delori P; Gunz G; Grisoli F; Weintraub BD
J Clin Endocrinol Metab; 1984 Nov; 59(5):817-24. PubMed ID: 6480809
[TBL] [Abstract][Full Text] [Related]
18. Bioactivity of serum and pituitary prolactin during the rat estrous cycle.
Blank MS; Ching MC; Dufau ML
Endocrinology; 1986 May; 118(5):1886-91. PubMed ID: 3698900
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of serum prolactin throughout the menstrual cycle and pregnancy in hyperprolactinemic women with normal ovarian function.
Larrea F; Escorza A; Valero A; Hernandez L; Cravioto MC; Diaz-Sanchez V
J Clin Endocrinol Metab; 1989 May; 68(5):982-7. PubMed ID: 2715295
[TBL] [Abstract][Full Text] [Related]
20. Correlation and comparison of Nb2 lymphoma cell bioassay with radioimmunoassay for human prolactin.
Subramanian MG; Spirtos NJ; Moghissi KS; Magyar DM; Hayes MF; Gala RR
Fertil Steril; 1984 Dec; 42(6):870-4. PubMed ID: 6500079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
